Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 19 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research

Fee For Service(FFS)

Full Time Equivalent(FTE)

Medicinal Chemistry

Synthetic Chemistry

Analytical Chemistry

Biology Research

Structural Biology

Cell Biology

Computational Biology & Molecular Modeling

Enzymology & Molecular Interactions

Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
APIs

Route Selection

Production Process Optimization

Clinical Sample Production

Impurity Traceability & Control

Generic Drug Process Study & Filing

Innovative Drug Process Study & Filing

Pharmaceutical preparation

Preformulation Study

Formulation Technology Research

Preparation Quality Research

Laboratory-scale Preparation Testing

Pilot-scale Preparation Testing

GMP-based Clinical Sample Production & Packaging

Formulation Stability Study

Consistency Evaluation

Analytical Method Development and Quality Control
CMC Filings
03 Preclinical Research
Pharmacology & Pharmacodynamics

Tumor Models

Digestive System Disease Models

Endocrine & Metabolic Disease Models

Inflammatory & Immune Diseases Models

Neural System Disease Models

Other Disease Models

Drug Safety Evaluation

Pharmacology & Toxicology Study

Safety Pharmacology

Histopathological Study

Clinicopathological Study

Drug Safety Evaluation Basic Information

Toxicokinetics

Pharmacokinetics

In Vitro Pharmacokinetic Assays

In Vivo Pharmacokinetic Assays

Bioanalysis

Macromolecular Drugs Bioanalysis

Micromolecular Drugs Bioanalysis

IND Filings
01 One-stop Integrated Services
Pharmaceutical Research Platform
Drug Discovery Plarform
One-stop API Process R&D Department
Translational Medicine Platform
Pharmaceutical Research CDMO Service Platform
Chemical Drug Development
Medicilon's CDMO Service Platform
Preclinical Research Services
02 Key Technical Services for Drug R&D
Process Department Solid Form Screening Platform
SEND Format Conversion Platform
Flow Cytometry Technology Platform
Safety Assessment Lab of Process Chemistry
Drug Forming Research Platform
Metabolite Identification (MetID) Service Platform
Cytokine and Biomarker Detection Platform
03 Innovative Drug Services
Nucleic Acid Drug R&D Platform
Non-clinical Research for Cellular Immunotherapies
mRNA Vaccine Bioanalysis Platform
PROTAC Drug Discovery Research Platform
ADC R&D Service Platform
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Drug Efficacy Evaluation System
Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases
IO Pharmacodynamic Model Evaluation Platform
05 Advanced Preparation R&D
Skin Topical Preparation R&D
Ophthalmic drug R&D platform
Inhalation drug R&D platform
06 Drug Analysis
07 Public Services
CLIENT CENTER
Intellectual Property Protection
Downloads
Partnerships
Newsletters
U.S.

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2023-03-20Market Events
Join Medicilon at SAPA-GP 2023 Annual Conference

Date: 3.31-4.1 2023

Location: King of Prussia, Pennsylvania

Learn more
2023-03-14Market Events
Join Medicilon at BioTrinity 2023: Catalysing Growth in the Life Sciences Industry

Date: April 25-26, 2023

Location: Etc. venues 155 Bishopsgate, London

Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CAREERS
Talent Development
Employee Activities
Campus Recruitment
Social Recruitment
Campus Recruitment
Campus Recruitment
Social Recruitment
Social Recruitment
Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Two Innovative Service Platforms of Medicilon were Selected as Shanghai International Service Trade Demonstration project| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Feb 23,2016
Medicilons VP of Biology was awarded Outstanding Contribution in Reviewing
Biochemical Pharmacology granted Dr. Jun Wang, Medicilon's VP of Biology, an "Outstanding Contribution in Reviewing” in recognition of the contribution made to the quality of
More
Medicilons VP of Biology was awarded Outstanding Contribution in Reviewing
Feb 22,2016
Chemical & Engineering News : "Reforming Drug Approval in China"
The Chemical & Engineering News (C&EN) recently published an article in the Feb 08, 2016 issue "Reforming Drug Approval in China".
More
Chemical & Engineering News : "Reforming Drug Approval in China"
Feb 03,2016
The special report written by Medicilon CEO, Dr. Chunlin Chen, was posted on Pharmaceutical Forum
The special report written by Medicilon CEO, Dr. Chunlin Chen, was posted on Pharmaceutical Forum of Zhejiang Pharmaceutical Association Dr. Chunlin Chen, CEO of Medicilon,
More
The special report written by Medicilon CEO, Dr. Chunlin Chen, was posted on Pharmaceutical Forum
Feb 03,2016
Medicilon is featured in Chemical & Engineering News (C&EN): "How The Internet Changed Chemistry”
The Chemical & Engineering News (C&EN) recently published a special issue "How The Internet Changed Chemistry”, which presented a very important point saying that "Internet
More
Medicilon is featured in Chemical & Engineering News (C&EN): "How The Internet Changed Chemistry”
Jan 20,2016
IVIS Lumina Series III Pre-clinical In Vivo Imaging Systems
01/20/2016 Medicilon Instruments' family has a new member: IVIS Lumina lt Series III Pre-clinical In Vivo Imaging Systems Medicilon new instrument, IVIS Lumina Series Pre-clinical
More
IVIS Lumina Series III Pre-clinical In Vivo Imaging Systems
Jan 07,2016
Medicilon installed Triple Quad 6500 system and in operation now
01/08/2016, Medicilon recently purchased Triple Quad 6500+ made by SCIEX for Biological Services.  This new purchase will enable Medicilon to expand and strength the Biological
More
Medicilon installed Triple Quad 6500 system and in operation now
Dec 25,2015
Christmas Greeting From MEDICILON!
Dear Colleagues and Friends,       Warmest Holiday Greetings to you and your families fromMEDICILON !       As the end of year is
More
Christmas Greeting From MEDICILON!
Nov 20,2015
Medicilon Biological Drugs Antibodies Laboratory Will Be Operated Soon
Medicilon's Biological Drugs (Antibodies) Laboratory will be operated soon.  Medicilon could provide more biology services to our clients combined with our usual biology services.  The
More
Medicilon Biological Drugs Antibodies Laboratory Will Be Operated Soon
Nov 12,2015
Biopharmaceutical Stability Research Test
The newly built vivarium by Medicilon has passed the audition of Shanghai Animal Committee.  Combined with the original vivarium, the vivarium capacity of Medicilon is
More
Biopharmaceutical Stability Research Test
Sep 17,2015
Dr. Chunlin Chen will participate the Zhejiang Overseas Senior-Level Biomedical Annual Meeting
The Zhejiang Overseas Senior-Level Organization was founded in Feb 2011 by entrepreneur and the scientists.  The organization currently has about 1,000 members from "Thousand People
More
Dr. Chunlin Chen will participate the Zhejiang Overseas Senior-Level Biomedical Annual Meeting
Jul 30,2015
Preclinical CRO - Medicilon
Medicilon (stock code: 688202. SH) is a drug research and development outsourcing service company (CRO). Pharmacology, pharmacokinetics, and toxicology evaluation are comprehensive technical service platforms that meet international standards.
More
Preclinical CRO - Medicilon
Jun 11,2015
Medicilon congratulate NeuPharma's New Drug to initiate the first-in-human Phase I Clinical Trial
Suzhou NeuPharma Co., Ltd announced that it has initiated the first-in-human Phase I clinical trial of RX108 in Australia.  RX108 is a novel small-molecule inhibitor
More
Medicilon congratulate NeuPharma's New Drug to initiate the first-in-human Phase I Clinical Trial
Stock Code
688202

Global

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880(U.S. - West Coast)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 24, Seochojungang-ro 8-gril, Seocho-gu, Seoul, 06643 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->